コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 lly transmitted in 28 (50.9%) pedigrees (P = non-significant).
2 for both DSP (80%) and PKP2 (91%) groups (P=non-significant).
3 5, 0.64 and 1.17, respectively (all p values non-significant).
4 predicted MIP and VC were less strong (both non-significant).
5 confidence interval 0.637-1.015; P = 0.0664, non-significant).
6 se subgroups (42.5% vs 49.6% respectively; p=non-significant).
7 ume, and mitral valve leaflet lengths (all P=non-significant).
8 rocumab versus control (interaction P-values non-significant).
9 time-dependent covariate, all hazards became non-significant.
10 scale-dependent, and were generally weak or non-significant.
11 all other differences in adverse events were non-significant.
12 g glucose and insulin the association became non-significant.
13 ternal linkage across the region was weak or non-significant.
14 ion with pro-inflammatory gene expression to non-significant.
15 ratio (HR) of developing T2D was similar and non-significant.
16 tion reported for these disorders is low and non-significant.
17 in KCCQ-TSS and CHQ-SAS dyspnoea score were non-significant.
18 sical or sensory disability only were mostly non-significant.
19 and the association of sex with dementia was non-significant.
20 ated, but differences between SB and TB were non-significant.
21 t circumference with risk of meningioma were non-significant.
22 Bay variant in the field trait were weak or non-significant.
23 zed models and those of PSG is statistically non-significant.
24 ing associations for IL-1RA or TGF-beta were non-significant.
25 cardiovascular events and mortality remained non-significant.
26 h outliers resulted in this difference being non-significant.
30 In the 600 mg group (86, 4.12 [SE 1.19]), a non-significant 22% reduction (95% CI -21.3 to 49.7; p=0
32 tin use during 3 years was associated with a non-significant 37% reduced tooth loss rate in the year
33 use during last sexual intercourse showed a non-significant 4.3% increase for females and a signific
34 t 7.5 mg/kg previously, CLA-ER resulted in a non-significant 58% decrease in C(max) and a non-signifi
35 3 [0.37-0.77]; I(2)=78.2%; three studies), a non-significant 6% lower risk of cancer incidence (HR 0.
37 llele of the EGF gene showed a statistically non-significant, 78% increased risk of HCC compared with
38 ischaemic heart disease (0.91, 0.85-0.98), a non-significant 9% lower risk of ischaemic stroke (0.91,
39 0.5%) allocated to avoid GCS, resulting in a non-significant absolute reduction in risk of 0.5% (95%
40 credibility classes of evidence (I to IV and non-significant) according to established criteria, comp
41 size of metformin on the primary outcome was non-significant (adjusted mean difference -0.029, 95% CI
42 gnitude (approximately 6%) but statistically non-significant (adjusted PR: 1.06; 95% CI: 0.97-1.16; p
43 and topiramate (0.64 [0.52-0.79]), and had a non-significant advantage compared with oxcarbazepine (1
44 (0.75 [0.63-0.90]), and estimates suggest a non-significant advantage for carbamazepine against lamo
46 d after adjusting for confounders and became non-significant after additionally adjusting for fatness
48 s III or IV (p < 0.05); pacing mode remained non-significant after adjustment for these factors (p =
51 .63, P = 0.042) with meningioma risk, albeit non-significant after correction for multiple testing.
55 al or memory-related cognitive function were non-significant and in opposing directions for DHCR7 and
57 e the difference in the primary endpoint was non-significant and the number of patients in the trial
59 ANES I (OR=0.36; 95% CI: 0.13 to 0.96) and a non-significant association in NHANES III (OR=0.73; 95%
60 ceptual speed -0.12 [0.04], p=0.0012), and a non-significant association was noted for visuospatial a
62 310] EU-wide), although the effect size was non-significant at all ages (0.49%, -0.04 to 1.02), and
64 nfants surviving without neuroimpairment was non-significant at the primary endpoint, timing of deliv
66 nts alone, computer-generated doses led to a non-significant benefit in all INR ranges (p=0.06), wher
68 Current published trials suggest a small, non-significant benefit of omega-3 FAs for major depress
71 36), though on multivariate analysis, only a non-significant but strong trend toward decreased mortal
72 n high-intensity systems species losses were non-significant but yield gains were substantial (+15.2%
73 .71-0.88, p<0.001) and a possible slight but non-significant cardiac mortality benefit (0.89, 0.78-1.
77 indings from four of the five studies showed non-significant changes in overall dementia occurrence.
81 the leg, while mechanoreceptors exhibited a non-significant contribution in both patients and contro
82 th time in the cortex (r(2)=0.545; p=0.015), non-significant correlation in the thalamus (r(2)=0.326)
83 orbidities, we generally observed weaker and non-significant correlations between climate and AA flar
85 smoke-free vehicle legislation, there was a non-significant decline in the slope for monthly emergen
86 ontraction strain showed a similar, although non-significant decrease (42.8+/-10.6% versus 39.3+/-8.3
88 d liposomal doxorubicin showed a minimal and non-significant decrease in LVEF with no change in HR or
89 Ferric derisomaltose was associated with a non-significant decrease in mean F2-isoprostane and no e
91 National BMI change for women ranged from non-significant decreases in 19 countries to increases o
93 n's group areas, for years 2 and 3, we noted non-significant decreases in NMR (odds ratio 0.93, 0.64-
94 -determined parasitemia in the PZQ arm and a non-significant decreasing trend in the placebo group (r
97 g different parameters, baseline data showed non-significant difference between injected eye group an
98 ans FAs during processing and storage showed non-significant difference in all goshtaba products (P >
100 in the community as a whole as shown by the non-significant difference in incidence among infants.
102 amples collected on days 14, 21, and 30 with non-significant differences among the three groups.
103 er adjustment for baseline score, there were non-significant differences between groups of -4.1 (95%
104 ective health measures, with most indicating non-significant differences between the Conversation Map
106 vanone activity was pronounced, resulting in non-significant differences in antioxidant activity betw
110 versus 9.6 +/- 6.3 pg/mL, P < 0.0001) while non-significant differences were observed with IL-10 (2.
112 andardized beta = -0.348, P = 0.008); (ii) a non-significant direct effect of periventricular white m
114 : 56% of patients were asymptomatic, 24% had non-significant disability, maintaining independency, 16
116 non-interdependent tasks (d = 0.108), and a non-significant effect in interdependent tasks (d = -0.0
117 .427 to +0.013, Z = -7.250, p < .0001) and a non-significant effect of hydrophobic statins (WMD: -0.1
121 n and control arms, respectively, yielding a non-significant effect on CVD incidence rate (1.92 and 2
125 ion with persistent variability, this led to non-significant effects of injury on all remaining neuro
127 ne effluxes into cortical superfusates, with non-significant effects on the efflux of glycine, glutam
129 roved; however, this effect rested on both a non-significant enhancement and diminution of 2-back and
130 effect size (ES) was small and statistically non-significant (ES 0.27; 95% confidence interval [95% C
132 her three subscales of the PAI-BOR (42.7% vs non-significant estimates for self-harm, negative relati
135 ts show no evidence of population structure (non-significant F(ST) < 0.001) for M. alfredi along this
137 omplementary capabilities for distinguishing non-significant fibrosis from significant fibrosis.
139 for HCMV (OR = 4.6; 95% CI = 0.9, 22.7), and non-significant for A. actinomycetemcomitans (OR = 2.0;
141 pend on creating lists of 'significant' and 'non-significant' genes based on ad hoc significance cuto
143 d but previous studies have reported weak or non-significant genetic correlations and five shared ris
145 for a diagnosis of IPF, as validated by the non-significant greater prognostic separation of an IPF
146 spite this, controlling for phylogeny yields non-significant group-level results for plants, suggesti
147 dosage's association with CVD-mortality was non-significant (HR = 0.60; 95% CI 0.35-1.03, p = 0.065)
148 er hospitalizations, however, the effect was non-significant (HR=1.03, 95% CI=1.00-1.06, p=0.061).
149 reversibility of 12% or greater, we noted a non-significant improvement in asthma exacerbation rate
151 eference with RG7713 (ES=0.8, p=0.047) and a non-significant improvement in the composite score (ES=0
153 mpact on lentiviral vector yields, but small non-significant improvements could be combined to increa
155 xpression and microbial alpha-diversity were non-significant in c.1414G > A (p.Asp472Asn) carriers.
156 test in the hand muscles, smaller in FDS and non-significant in EDC, irrespective of whether stimulat
158 (GDP) per person (-0.055, p=0.0009) becomes non-significant in the presence of norm-related measures
159 roup was found, while the association became non-significant in those with higher education (P for AC
160 e distant metastasis had a 27% statistically non-significant increase (HR = 1.27, 95% CI 0.88-1.83).
161 L, respectively, and we recorded a small and non-significant increase for haemoglobin A1c (0.04% [-0.
162 plus cyclic progestin was associated with a non-significant increase in coronary heart disease event
164 nts (6.7%vs 8.2% per year, p<0.0001), with a non-significant increase in haemorrhagic stroke but redu
165 previous IS, statins were associated with a non-significant increase in ICH (RR 1.36, 95% CI 0.96 to
167 s a percentage of the averaged zonal area, a non-significant increase in new input from the body was
168 -90; p=0.005), but this was accompanied by a non-significant increase in perinatal and infant mortali
169 se analogues had no effect on the modest and non-significant increase in phrenic nerve discharge evok
170 (400 um) applied to the cytoplasm produced a non-significant increase in spark frequency and reduced
171 Significant decrease in the SH content and non-significant increase in SS content was observed at h
173 e of haemorrhagic stroke and a 6% (-7 to 18) non-significant increase in the incidence of ischaemic s
174 ent per 1000 patients treated [75-206] and a non-significant increase in the number dead (nine per 10
175 ded significant improvements in PASI75 and a non-significant increase in the proportion of patients w
176 ar after cessation of treatment, there was a non-significant increase in the risks of APTC endpoints.
177 of the DLPFC (Cohen's d = 0.81) as well as a non-significant increase in this ratio for the DLPFC as
178 context was associated with a statistically non-significant increase in total expenditures (average
179 0% to 29%; p=0.054) in southern Africa and a non-significant increase of 3% (-0.9 to 16; p=0.618) in
180 in vivo within first 120 h though there is a non-significant increase of active caspase 3 at 120 h.
182 ble solids, and titratable acidity exhibited non-significant increase up to 30min of exposure time.
183 ed by a significant reduction (P < 0.05) and non-significant increase, respectively, of alpha4 and al
184 CI, 1.13 to 2.15), as well as a possible but non-significant increased risk of myocardial infarction
187 [95% CI 1.02-2.07], p=0.04), due in part to non-significant increases in peri-procedural myocardial
188 ith infants; and small, mostly statistically non-significant, increases in parental psychological dis
196 co-admistration reduced all connectivity to non-significant levels, and, like phMRI measures of morp
198 ormalized dwell time analyses yielded mostly non-significant main effects of the environment, indicat
200 as 53 +/- 3.2 (n = 47), 51 +/- 3.2 (n = 35) (non-significant, ns), and 33 +/- 1.9 (n = 32) (p < 0.01)
201 52 +/- 2.1 (n = 46) and 54 +/- 1.9 (n = 38) (non-significant, ns), respectively, whereas in old wild-
202 In the same 25 patients, 34 CAV lesions with non-significant obstructions were identified as referenc
203 ecancerous lesions, although an elevated but non-significant odds ratio (OR) for gastric precancerous
205 8%, RR=0.72, 95% CI: 0.56-0.94), and, albeit non-significant, of 30-day mortality (0.46% vs 0.64%, RR
207 h positive association in some subgroups and non-significant or negative association in other subgrou
210 her odds of being fully reported compared to non-significant outcomes (range of odds ratios: 2.2 to 4
211 s, whereas mature data yielded statistically non-significant overall survival findings for 24 (63%) i
213 d in detail, including misinterpretation of "non-significant" p-values as evidence for the null hypot
214 t specific cell-surface proteins, although a non-significant pattern toward increased total FimA-spec
215 a positive, a hump-shaped, a U-shaped and a non-significant pattern, depending on assembly sequence.
216 es when applied during subjective day, while non-significant phase shifts were seen after 5-HT applic
218 easures (n = 7)(I2 = 78.8%) and a modest but non-significant pooled estimate (MRR1.14,95%CI 0.95-1.37
221 d significant, while safety climate became a non-significant predictor of mortality odds (OR 0.940, p
226 ages is revised to 0.38 when considering the non-significant rate reduction in the control villages.
230 ion in men with HIV (0.38, 0.18-0.81), and a non-significant reduction in incident syphilis in men wi
231 ion in degree of anaemia between groups, and non-significant reduction in RBC transfusion in the rest
232 schaemic stroke was associated with a small, non-significant reduction in risk of death at 3 years, b
233 = 93.9%) and, with a similar, statistically non-significant reduction in sensitization (RR = 0.78; 9
234 onatal mortality (0.77, 0.65-0.90), and a 9% non-significant reduction in stillbirths (0.91, 0.79-1.0
235 type 2 diabetes was associated with a small, non-significant reduction in the incidence of cardiovasc
236 ion of symptoms was 12.8 years (SD: 15.3), a non-significant reduction of 0.6 years (95% CI: -2, 0.8;
238 aplotypes, AGC and GGC, were associated with non-significant reductions in breast cancer risk, and th
239 s in the plasma plus standard care group had non-significant reductions in days in hospital (median 6
240 dentate gyrus molecular layer, with smaller, non-significant reductions in the CA1 and CA3 regions.
241 aRR] = 1.02, 95% CI 0.36-2.91, p = 0.97) and non-significant reductions in the TPR (26.5% pre-interve
248 d with low heterogeneity and a statistically non-significant risk of small study bias, resulting in a
249 ective, single-arm, multicenter, open-label, non-significant risk trial that evaluated the safety and
250 tionated heparin (0.81 [0.61-1.08]) led to a non-significant shift towards worse modified Rankin Scal
251 Compared with ASC alone, we noted a small, non-significant survival benefit for ASC plus chemothera
259 between direct and indirect strategies were non-significant, the difference in favour of direct inte
262 le male growth during the fall and a similar non-significant trend among adult males, and (3) spatial
268 body mass in exclosures resulted from: (1) a non-significant trend of increased survival of large mal
269 es in cortical NE and 5-HT while producing a non-significant trend to increase cortical levels of nor
271 ard swallowing therapy was associated with a non-significant trend toward a reduction in death (0.80,
272 eographic location and study quality, with a non-significant trend towards a dose-response relationsh
273 he antioxidant enzyme peroxiredoxin-V, and a non-significant trend towards decreased manganese supero
278 ittent hypoxia (P < 0.05), and a similar but non-significant trend was observed after sustained hypox
281 Intensive BP-lowering treatment showed a (non-significant) trend for an association with lower 3-m
282 P area, the southern part showed a downward (non-significant) trend in direct obstetric mortality (0.
285 For questions (1) and (2), we find weak and non-significant trends in the expected directions, which
287 Irrespective of stroke subtype, there were non-significant trends towards future ICH with statins.
290 ion of Cd86 (marker of inflammatory M1), and non-significant upregulation of Arg1 (marker of M2).
295 n individual tracts, all associations became non-significant when analyses were adjusted for multiple
296 ly noted on the ADHD Rating Scale-IV (became non-significant when corrected for multiple comparisons)
297 howed that its partial predictive effect was non-significant when depressive symptomatology and AD bi
298 cant when the most stable genes were used to non-significant when the least stable genes were used.
299 anges in financial and quality measures were non-significant, with the exception of hospital closures